Industry Insights
Sep 17, 2026 · 1 min read · 24,113 views
How past Endpoints 11 winners fared as the biotech industry rebounded
D
Daniel Park
Editorial · Sep 17, 2026
News reviews 77 E11 startups; highlights include Candid's $2B UCB buyout, Isomorphic Labs' $2.1B raise, Orca Bio's FDA approval, and Areteia's closure
← Previous
Biotech venture funding: Who's raising and where the money is going
Next →
FDA says initial rejections of new drugs have declined
